Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleArticle

Ethynylestradiol-Mediated Induction of HepaticCYP3A9 in Female Rats: Implication for Cyclosporine Metabolism

Walter Jäger, Maria Almira Correia, Lester M. Bornheim, Axel Mahnke, Walter G. Hanstein, Linlong Xue and Leslie Z. Benet
Drug Metabolism and Disposition December 1999, 27 (12) 1505-1511;
Walter Jäger
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maria Almira Correia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lester M. Bornheim
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Axel Mahnke
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Walter G. Hanstein
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Linlong Xue
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Leslie Z. Benet
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

Repeated treatment of female rats with the synthetic estrogen ethynylestradiol (EE2) increases the formation of the cyclosporine A (CyA) metabolites AM1c and AM9 by 3-fold, whereas the formation of AM1 and AM4N is not significantly enhanced. The formation of all four CyA metabolites was inhibited by greater than 80% by the CYP3A-selective substrate midazolam or polyclonal anti-rat CYP3A IgGs in liver microsomes of untreated and EE2-induced rats. In contrast, anti-rat CYP2C6 IgGs had little effect, indicating the involvement of a CYP3A but not 2C6 in this EE2-stimulated CyA metabolism. Semiquantitative reverse-transcriptase polymerase chain reaction was used to determine the mRNA content for four CYP3A genes (CYP3A2, CYP3A9, CYP3A18, and CYP3A23) in livers of control and EE2-treated female rats. EE2 selectively induced CYP3A9 by 3.3-fold whereas the expression of CYP3A18 and CYP3A23 was slightly decreased; neither CYP3A2 mRNA nor CYP3A1 mRNA was detectable in these EE2-treated livers. To determine whether rat liver microsomal CYP3A9 was indeed responsible for the EE2-stimulated CyA metabolism, a recombinant CYP3A9 was heterologously expressed in Escherichia coli. When functionally reconstituted, this enzyme was active in metabolizing CyA preferentially to its AM9 and AM1c metabolites as compared with CYP3A4. These findings thus support the notion that the increased CyA-metabolizing capacity of EE2-treated female rat liver microsomes is due to the induction of the CYP3A9 enzyme.

Footnotes

  • Send reprint requests to: Walter Jäger, Ph.D., Institute of Pharmaceutical Chemistry, University of Vienna, Althanstrasse 14, A-1090 Vienna, Austria. E-mail:wjaeger{at}speedy.pch.univie.ac.at

  • This work was supported in part by National Institutes of Health Grants DK 26506 (M.A.C.), DA 04265 (L.M.B.), GM 26691 (L.Z.B.), and the Deutsche Forschungsgemeinschaft Ha 1124/6–1 (W.G.H.). A.M. thanks the Gottlieb Daimler- und Karl Benz-Stiftung for a scholarship. The authors also acknowledge the use of the University of California at San Francisco Liver Center Spectrophotometry facility supported by the National Institutes of Health Liver Core Center Grant NIDDK 26743.

  • ↵2 In common with many other P-450 suicide inactivators such as secobarbital, allylisopropylacetamide, and cannabidiol, EE2, by virtue of also being an excellent lipophilic substrate, would inactivate the enzyme on acute administration, but on repeated administration would induce rat liver CYPs that may be different from that/those initially inactivated (Bornheim LM and Correia MA, 1989a,b; and references therein).

  • Abbreviations used are::
    CyA
    cyclosporine
    EE2
    ethynylestradiol
    P-450
    cytochrome P-450
    RT
    reverse transcriptase
    PCR
    polymerase chain reaction
    DX
    dexamethasone
    GAPDH
    glyceraldehyde phosphate dehydrogenase
    DMSO
    dimethyl sulfoxide
    • Received March 2, 1999.
    • Accepted September 23, 1999.
  • The American Society for Pharmacology and Experimental Therapeutics
View Full Text

 

DMD articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 27 (12)
Drug Metabolism and Disposition
Vol. 27, Issue 12
1 Dec 1999
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Ethynylestradiol-Mediated Induction of HepaticCYP3A9 in Female Rats: Implication for Cyclosporine Metabolism
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Ethynylestradiol-Mediated Induction of HepaticCYP3A9 in Female Rats: Implication for Cyclosporine Metabolism

Walter Jäger, Maria Almira Correia, Lester M. Bornheim, Axel Mahnke, Walter G. Hanstein, Linlong Xue and Leslie Z. Benet
Drug Metabolism and Disposition December 1, 1999, 27 (12) 1505-1511;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Ethynylestradiol-Mediated Induction of HepaticCYP3A9 in Female Rats: Implication for Cyclosporine Metabolism

Walter Jäger, Maria Almira Correia, Lester M. Bornheim, Axel Mahnke, Walter G. Hanstein, Linlong Xue and Leslie Z. Benet
Drug Metabolism and Disposition December 1, 1999, 27 (12) 1505-1511;
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Experimental Procedures
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • CYP3A-Catalyzed Deoxycholate and Glycodeoxycholate Oxidation
  • Variants linked with hepatic CYP2D6 expression and activity
  • Cytochrome P450 4F11 in lung cancer
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics